Study design

Comparative Study

Study time

2019.1-2020.1

Country

Iran

Object

patients who underwent SP-EPP were entered prospectively in an institutiol review board (IRB)-approved database. All consecutive patients with localized pros_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x005f_x0002_tate cancer treated with MP-RARP during the study period were used as a control group. All patients were treated in the same tertiary care center by three experienced robotic surgeons (>1000 RARPs; one dedicated to SP-EPP and MP-RARP, and two dedicated to MP-RARP).

Sample size

210

Topic classification

Focus on RARP

Keypoint

Pure single-site SP-EPP was associated with a shorter length of stay as well as a decreased need for postoperative pain medication and rcotic administration in comparison with conventiol transperitoneal multiport prostatectomy, with comparable postoperative complications and readmission rate.

Year